# PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2024 · $1,020,618

## Abstract

PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER

## Key facts

- **NIH application ID:** 11160400
- **Project number:** 75N91019D00012-P00006-759102000001-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** DAVID MCCORMICK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,020,618
- **Award type:** —
- **Project period:** 2020-09-08 → 2025-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11160400

## Citation

> US National Institutes of Health, RePORTER application 11160400, PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV (75N91019D00012-P00006-759102000001-1). Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/grant/nih/11160400. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*